AbbVie ends deal for Infinity's duvelisib

Infinity Pharmaceuticals Inc. (NASDAQ:INFI) said AbbVie Inc. (NYSE:ABBV) ended the companies' 2014 deal

Read the full 138 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE